Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors
{{output}}
Defective host defenses later in life are associated with changes in immune cell activities, suggesting that age-specific considerations are needed in immunotherapy approaches. In this study, we found that PD-1 and CTLA4-based cancer immunotherapies are unable... ...
